Yahoo Web Search

Search results

    • Guardant Health Stock Jumps 12%

      Guardant Health Stock Jumps 12%

      Barrons.com· 48 minutes ago

      The FDA is expected to decide whether or not to approve the blood test, Shield, later this year.Read the full article

    • FDA monitoring plastic syringe supply chain

      Politico· 2 hours ago

      The recalls come amid an uptick in product import alerts from the FDA and after the agency’s latest warning to consumers and health care providers not to use the foreign-made ...